Request Deal Involvement
Sofinnova Investments and General Catalyst led a $155m Series B round in ArriVent Biopharma.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Cooley
or
Principals
target
ARRIVENT BIOPHARMA
bidder
SOFINNOVA INVESTMENTS
bidder
GENERAL CATALYST PARTNERS
bidder
CATALIO CAPITAL MANAGEMENT
bidder
HBM HEALTHCARE INVESTMENTS
bidder
SHANGHAI HEALTHCARE CAPITAL
bidder
SEQUOIA CAPITAL
bidder
AIHC CAPITAL
bidder
TERRA MAGNUM CAPITAL
bidder
UNICORN CAPITAL PARTNERS
bidder
LILLY ASIA VENTURES
bidder
ORBIMED PE
bidder
OCTAGON CAPITAL
bidder
SIRONA CAPITAL
bidder
BOYU CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite